Symptomatic Irreversible Pulpitis
Conditions
Brief summary
The aim of this study is to clinically compare post-operative pain levels after ultrasonic activation of Ceraseal bioceramic sealer versus non-activated bioceramic sealer for patients with symptomatic irreversible pulpitis related to mandibular premolar teeth.
Detailed description
To clinically compare post-operative pain levels after ultrasonic activation of Ceraseal bioceramic sealer versus non-activated bioceramic sealer for patients with symptomatic irreversible pulpitis related to mandibular premolar teeth.Ultrasonic activation of Ceraseal bioceramic sealer for 20 seconds using non cutting ultrasonic tip.
Interventions
activation of bioceramic sealer using ultrasonic tip for 20 seconds in buccolingual and mesiodistal direction
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients above 18 years old and to 50. * Male or female. * Patients seeking root canal treatment. * Mandibular posterior teeth with Symptomatic irreversible pulpitis with preoperative sharp, moderate, or severe pain with normal periapical radiographic appearance or slight widening in lamina dura. * Systematically healthy patient (ASA I, II). * Patient who can understand modified VAS and sign informed consent
Exclusion criteria
* Medically compromised patients having significant systemic disorders. (ASA III or IV). * History of intolerance to NSAIDS. * Patients with two or more adjacent teeth requiring endodontic treatment. * External root resorption. * Internal root resorption. * Vertical root fracture. * Periapical lesion. * Association with swelling. * Acute peri-apical abscess or acute exacerbation of a chronic abscess. * Pregnancy. * Use of ibuprofen in the last 12 hour. * Bleeding disorder. * Long term corticosteroid use. * Mobility Grade II or III. * Pocket depth more than 5mm. * Previous root canal therapy. * Non-restorability. * TMJ problems, bruxism, clenching or traumatic occlusion. * Inability to perceive the given instructions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative pain | 6 hours | intensity of pain on modified Visual analogue scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| number of analgesic tablets taken by patient after endodontic treatment | up to 48 hours postoperatively | number of analgesics taken by patient in 1st 48 hours |
| Sealer Extrusion laterally and periapically | Immediately after obturation. | presence or absence of sealer extrusion |
Countries
Egypt